Medical Prognosis Institute A/S - Interim Report First Half 2015 - Allarity Therapeutics

‹ Back

Medical Prognosis Institute A/S – Interim Report First Half 2015

31/08/2015

Hoersholm; August 31^st 2015 – Medical Prognosis Institute A/S (MPI) announces the Company’s Interim Report First Half 2015.

Interim Report First Half 2015

The Board of Directors for Medical Prognosis Institute A/S has today discussed and approved the Interim Report First Half 2015.

Please find the full Interim report on www.medical-prognosis.com.

For further information, please contact
Peter Buhl Jensen, CEO
e-mail: [email protected]
Cell Phone: +45 21 60 89 22

Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark

Sign up for press releases and receive relevant information about Allarity Therapeutics A/S

Press Contact

For any inquiries, please contact:

[email protected]

Newest Press Releases

Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology

Mar 17, 2025

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 13, 2025

Copyright © 2025 Allarity Therapeutics, Inc. All Rights Reserved.

Unless otherwise specified, all product and service name appearing in this internet site are trademark owned by or licensed to Allarity, its subsidiaries or affiliates. No use of any Allarity trademark, trade name, or trade dress in this site may be made without the prior written authorization of Allarity, except to identify the product or services of company.

United States:
24 School Street, 2nd Floor,
Boston, MA 02108
USA
Tel. +1 401-426-4664

Denmark:
Venlighedsvej 1
2970 Hoersholm
Denmark
Tel. +45 88 74 24 14
CVR: 34623562